A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
Clinical trial NCT07582783 · RECRUITING
Trial details
- NCT number
- NCT07582783
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-15
- Primary completion
- 2028-09-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.